Cotherix is based out of South San Francisco. Focuses on licensing, developing and commercializing therapeutic products for the treatment of cardiopulmonary and other chronic diseases. Ventavis, the company's first product, is designed for the treatment of pulmonary arterial hypertension.Whalewisdom has at least 17 Form 4 filings The firm has no submitted 13F filings and does not appear to be an investment advisor.
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
COTHERIX INC5000 SHORELINE COURT
SOUTH SAN FRANCISCO CA 94080
Business Phone: 650-808-6500
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Recent SEC Filings
Filing | Date |
---|---|
CT ORDER | 2011-08-10 |